Phase III trial (NGR 015) with NGR-hTNF plus best investigator choice (BIC) versus placebo plus BIC in previously treated patients with advanced ma...

Date 30 October 2015
Event Bridging Gaps in Oncology 2015
Session Trending in Oncology
Topics Mesothelioma
Presenter R. Gaafar, EG